Purchases and Sales Made in Q3 2019 in Stealth Bio Therapeutics Corp (MITO)
This table provides information about the institutional ownership of Stealth Bio Therapeutics Corp (MITO) during Q3 2019. The information is specifically focused on institutions that hold shares of Stealth BioTherapeutics Corp.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2019
Q3 2019
|
Kingdon Capital Management, L.L.C.
New York, NY |
BUY
|
- |
220K+ 123.12% |
$1.15M - $2.94M
|
398K
$0
|
|
|
Nov 14, 2019
Q3 2019
|
Ubs Group Ag
|
BUY
|
- |
4.63K+ 222.63% |
$24.2K - $61.9K
|
6.71K
$0
|
|
|
Nov 14, 2019
Q3 2019
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
133+ 61.86% |
$694 - $1.78K
|
348
$0
|
|
|
Nov 13, 2019
Q3 2019
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 05, 2019
Q3 2019
|
Catalyst Capital Advisors LLC
Huntington, NY |
SELL
|
- |
-568Closed |
$2.96K - $7.59K
|
0
$0
|
|
|
Nov 14, 2019
Q3 2019
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-9.37K- 26.16% |
$48.9K - $125K
|
26.4K
$0
|